Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor (rhu GM-CSF) as Adjuvant Therapy for Invasive Fungal Diseases.
Journal: Open forum infectious diseases
Published: August 02, 2022
GM-CSF: Orchestrating the Pulmonary Response to Infection.
Journal: Frontiers in pharmacology
Published: July 02, 2021
Invasive fungal disease and the immunocompromised host including allogeneic hematopoietic cell transplant recipients: Improved understanding and new strategic approach with sargramostim.
Journal: Clinical immunology (Orlando, Fla.)
Published: February 04, 2021
Immune Immunomodulation in Coronavirus Disease 2019 (COVID-19): Strategic Considerations for Personalized Therapeutic Intervention.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: May 16, 2020
Recombinant human granulocyte macrophage-colony stimulating factor expressed in yeast (sargramostim): A potential ally to combat serious infections.
Journal: Clinical immunology (Orlando, Fla.)
Published: August 09, 2019
Examining the importance of laboratory and diagnostic testing when treating and diagnosing onychomycosis.
Journal: International journal of dermatology
Published: January 10, 2017
Showing 1-6 of 6
Last Updated: 09/26/2026